oxymatrine has been researched along with transforming growth factor beta in 8 studies
Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
---|---|---|---|---|---|
412 | 16 | 270 | 49,119 | 560 | 17,610 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CW; Fan, Z; Jia, Y; Lu, L; Mao, Y; Peng, YS; Song, Y; Yang, W; Zeng, M; Zhu, HY | 1 |
Jin, YR; Li, CH; Piao, DM; Piao, XX; Wu, CS | 1 |
Jiang, MD; Qin, JP; Wu, XL; Xu, H; Zeng, WZ | 1 |
Li, Z; Liu, L; Lu, W; Ma, Z | 1 |
Fang, T; Shen, X; Xu, L; Xu, Y; Yang, Y | 1 |
Lu, ML; Xia, SH; Xiang, XH | 1 |
Ahn, KS; Baek, SH; Blough, BE; Jung, YY; Namjoshi, OA; Narula, AS | 1 |
Dutta, BJ; Ganti, SS; Gupta, GD; Mehan, S; Seksaria, S; Singh, A | 1 |
2 review(s) available for oxymatrine and transforming growth factor beta
Article | Year |
---|---|
Potential Signaling Pathways Involved in the Clinical Application of Oxymatrine.
Topics: Alkaloids; Arginine; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-bcl-2; Quinolizines; Signal Transduction; Sophora; STAT Transcription Factors; Toll-Like Receptors; Transforming Growth Factor beta | 2016 |
Oxymatrine and insulin resistance: Focusing on mechanistic intricacies involve in diabetes associated cardiomyopathy via SIRT1/AMPK and TGF-β signaling pathway.
Topics: Alkaloids; AMP-Activated Protein Kinases; Diabetes Mellitus; Diabetic Cardiomyopathies; Humans; Insulin Resistance; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirtuin 1; Transforming Growth Factor beta | 2023 |
6 other study(ies) available for oxymatrine and transforming growth factor beta
Article | Year |
---|---|
[Prophylactic and therapeutic effect of oxymatrine on D-galactosamine-induced rat liver fibrosis].
Topics: Alkaloids; Animals; Anti-Arrhythmia Agents; Calcium Hydroxide; Chemoprevention; Disease Models, Animal; Galactosamine; Liver Cirrhosis; Liver Function Tests; Male; Quinolizines; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Transforming Growth Factor beta | 2002 |
Treatment of pig serum-induced rat liver fibrosis with Boschniakia rossica, oxymatrine and interferon-alpha.
Topics: Alkaloids; Animals; Antiviral Agents; Biomarkers; Blood Proteins; Disease Models, Animal; Drugs, Chinese Herbal; Immunohistochemistry; Interferon-alpha; Liver Cirrhosis; Male; Organ Size; Orobanchaceae; Quinolizines; Rats; Rats, Wistar; RNA, Messenger; Swine; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis.
Topics: Alkaloids; Animals; Antiviral Agents; Carbon Tetrachloride; CREB-Binding Protein; Liver Cirrhosis; Male; Models, Biological; Quinolizines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Smad Proteins; Smad3 Protein; Smad7 Protein; Transforming Growth Factor beta | 2008 |
Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antiviral Agents; Bleomycin; Lung; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Peroxidase; Pulmonary Fibrosis; Quinolizines; Signal Transduction; Smad Proteins; Sophora; Transforming Growth Factor beta | 2012 |
[Protective effect of TGF-beta-Smads signal-based oxymatrine on myocardial fibrosis induced by acute myocardial infarction in rats].
Topics: Acute Disease; Alkaloids; Animals; Fibrosis; Male; Myocardial Infarction; Myocardium; Quinolizines; Rats; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2012 |
Potential function of oxymatrine as a novel suppressor of epithelial-to-mesenchymal transition in lung tumor cells.
Topics: Adaptor Proteins, Signal Transducing; Alkaloids; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; Models, Biological; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinolizines; Ribosomal Protein S6 Kinases; Signal Transduction; TOR Serine-Threonine Kinases; Transforming Growth Factor beta | 2021 |